Please login to the form below

NHS England

This page shows the latest NHS England news and features for those working in and with pharma, biotech and healthcare.

NHS England will make PrEP for HIV available in April

The UK Department of Health has confirmed that a drug that prevents the transmission of HIV will be available in England next month. ... Prior to the start of the trial there was a protracted and emotive battle between the DH and PrEP advocates over NHS

Latest news

Novartis plans inclisiran trial in the UK

The company will work in partnership with the Nuffield Department of Population Health at Oxford University, the NHS and the National Institute for Health Research (NIHR) as part of this programme. ... In January, Novartis announced that it has teamed up
J&J begins search for a coronavirus vaccine as confirmed cases rise

for England. ... The NHS is extremely well-prepared and used to managing infections and we are already working rapidly to identify any contacts the patients had, to prevent further spread" Whitty said.
EMA begins review of Kite’s CAR-T for mantle cell lymphoma

Both Kymriah and Yescarta are available on for use on the NHS in England, with the health service quickly recommending these treatments – which NHS England chief executive Simon Stevens hailed as
Immuno-oncology, personalised medicine continues to drive pharma sector

When all was said and done, NICE decided that the drug was too expensive to be approved for use on the NHS, but maintained that it would be open to future ... Personalised medicines have been identified as key treatments by the UK’s health service,
NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi

Last June, NHS England chief executive Simon Stevens (pictured left) announced that the health service wants to fast-track tumour-agnostic drugs, like Vitrakvi and Rozlytrek. ... Stevens said that NHS England would attempt to work with industry to

More from news
Approximately 77 fully matching, plus 461 partially matching documents found.

Latest Intelligence

Developing a COVID-19 vaccine

Victory of the people in the fight against COVID-19. NHS sees record numbers respond to call for volunteers. ... Our team is now working flat out with colleagues in NHS England to process the many thousands of applications we’ve received, so we can get
The global antibiotic crisis: a 2020 perspective

In the UK, NHS England is collaborating with the National Institute for Health and Care Excellence (NICE) on a pilot project under which NHS England will evaluate and procure two AMR ... It will test a ‘subscription’ style model that pays
The roaring ‘20s and Generation Z

So campaigns which focus on health inequalities are likely to better received by Parliament, as well as by NHS England which dedicated a whole chapter to the subject in the Long ... Of the new and returning intake, we estimate that 41 (just over a quarter
Patient journey mapping: exploring the clinical and the emotional journey

The production of a clinical pathway can be achieved by analysing Hospital Episode Statistics (HES) data: a records-based system that covers all NHS Trusts in England. ... While all data is pseudonymised to ensure patient confidentiality, the data
Evolution or revolution: the latest review of NICE methods

patients and the life sciences industry, as well as NHS England and DHSC. ... They include the Accelerated Access Collaboration (AAC) – a fast-track route into the NHS for ‘breakthrough’ medicines and technologies – as well as the development of

More from intelligence
Approximately 4 fully matching, plus 59 partially matching documents found.

Latest appointments

New faces at Lucid Group and ZPB Associates

Following two years working to integrate the new guidance into NHS organisations, Goodwin moved into the pharmaceutical sector. ... The agency’s combined teams have a wealth of experience with team members having previously worked at hospital trusts,
Lexington Communications bolsters team with a trio of new-hires

The new senior advisory board will consist of Professor Mike Bewick (pictured right), who joins from NHS England as its deputy medical.
Prof Sir Mike Richards joins Incisive Health as senior counsel

In his most recent role Sir Mike led the inspection, quality and safety agenda for hospitals and prior to that he served in senior clinical roles at NHS England and the ... In July 2012 he was appointed as Director for Reducing Premature Mortality on the
NHS England names director for new models of care

Samantha Jones recently won NHS chief executive of the year. NHS England has named award-winning hospital chief executive Samantha Jones to head the development and implement of new models of ... Jones now assumes the role of director of new models of
New head of strategy for Saatchi & Saatchi Health

Critchley joins from Serco where she served as strategic brand planner at its recently-created healthcare business, which provides services to support the NHS in England.

More from appointments
Approximately 3 fully matching, plus 13 partially matching documents found.

Latest from PMHub

Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession

The panel for this webinar consists of:. Anusha Patel, High Cost Medicines and Regional Homecare Lead Pharmacist for the East Midlands; Advisor to NICE and NHS England.
Does digital primary care offer a sustainable solution?

In the 2019 joint report from the Health Foundation, Kings Fund and Nuffield Trust closing the gap, it was reported that the NHS in England has 2, 500 fewer GPs than ... In September, NHS England published a response to a consultation that aimed to
Covid-19: how is it impacting on the NHS Long-term Plan?

This enabled NHS England to command all NHS resources across England and NHS organisations were instructed not to stockpile medicines, devices or consumables. ... NHS England was tasked with identifying risk groups and building an intervention plan after
Improving patient concordance – where does industry fit in?

Whichever term is used, poor concordance costs millions each year. According to 2019 figures from NHS England, an estimated 50% of patients do not take their medicines as prescribed.
Covid-19: what could it mean for the diabetic population?

On March 28, Stephen Powis, National Medical Director of NHS England, said that the UK would have done "very well" if there were fewer than 20, 000 coronavirus deaths. ... Ends. National Diabetes Audit, 2017-18 Report 2a: Complications and Mortality